Accumulating evidence indicated that TREM2 exerted neuroprotection by alleviating neuroinflammation in experimental cerebral ischemia (Kawabori et al., 2015, Wu et al., 2017b, Zhai et al., 2017). The gene discussed is TREM2; the disease is brain ischemia.